ProFibrix – Exit
ProFibrix leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets.
Sector: | Therapeutics & Drug Delivery |
Country: | The Netherlands |
Status: | Exit through trade sale |